T. Sugimoto

542 total citations
18 papers, 436 citations indexed

About

T. Sugimoto is a scholar working on Molecular Biology, Nephrology and Oncology. According to data from OpenAlex, T. Sugimoto has authored 18 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Nephrology and 7 papers in Oncology. Recurrent topics in T. Sugimoto's work include Bone health and treatments (7 papers), Parathyroid Disorders and Treatments (6 papers) and Bone health and osteoporosis research (4 papers). T. Sugimoto is often cited by papers focused on Bone health and treatments (7 papers), Parathyroid Disorders and Treatments (6 papers) and Bone health and osteoporosis research (4 papers). T. Sugimoto collaborates with scholars based in Japan, Australia and Germany. T. Sugimoto's co-authors include M. Yamauchi, Kazuo Chihara, Hiroshi Kaji, N. Ogawa, Toru Yamaguchi, Masahiro Yamamoto, Shozo Yano, K Chihara, Tomohiro Yamaguchi and Sachiko Yano and has published in prestigious journals such as Journal of Bone and Mineral Research, Osteoporosis International and Hormone and Metabolic Research.

In The Last Decade

T. Sugimoto

18 papers receiving 428 citations

Peers

Countries citing papers authored by T. Sugimoto

Since Specialization

Citations

This map shows the geographic impact of T. Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Sugimoto more than expected).

Fields of papers citing papers by T. Sugimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Sugimoto. The network helps show where T. Sugimoto may publish in the future.

Co-authorship network of co-authors of T. Sugimoto

This figure shows the co-authorship network connecting the top 25 collaborators of T. Sugimoto. A scholar is included among the top collaborators of T. Sugimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Sugimoto. T. Sugimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT 2013 ·Osteoporosis International ·M. Ito, (unknown), Masao Fukunaga, Teruki Sone, T. Sugimoto, Masataka Shiraki, Yoshiki Nishizawà, T. Nakamura	25
2	Comparisons of Serum Sclerostin Levels among Patients with Postmenopausal Osteoporosis, Primary Hyperparathyroidism and Osteomalacia 2011 ·Experimental and Clinical Endocrinology & Diabetes ·Hiroshi Kaji, Yasuo Imanishi, T. Sugimoto, (unknown)	18
3	The Calcium-sensing Receptor (CaR) is Involved in Strontium Ranelate-induced Osteoblast Differentiation and Mineralization 2010 ·Hormone and Metabolic Research ·(unknown), Tomohiro Yamaguchi, Sachiko Yano, M. Yamauchi, T. Sugimoto	73
4	Effect of retinoic acid on the proliferation and alkaline phosphatase activity of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes 2009 ·Experimental and Clinical Endocrinology & Diabetes ·Hiroshi Kaji, T. Sugimoto, Masanori Kanatani, Junichi Kano, M. Fukase, Kazuo Chihara	2
5	Inhibition of the Mevalonate Pathway Rescues the Dexamethasone-induced Suppression of the Mineralization in Osteoblasts via Enhancing Bone Morphogenetic Protein-2 Signal 2009 ·Hormone and Metabolic Research ·Ippei Kanazawa, (unknown), (unknown), Kensuke Hayashi, (unknown), T. Sugimoto	6
6	Low Density Lipoprotein-Cholesterol Levels Affect Vertebral Fracture Risk in Female Patients with Primary Hyperparathyroidism 2009 ·Experimental and Clinical Endocrinology & Diabetes ·Hiroshi Kaji, (unknown), Yasuhiro Inoue, T. Sugimoto	4
7	Parathyroid Hormone Upregulates BMP-2 mRNA Expression Through Mevalonate Kinase and Rho Kinase Inhibition in Osteoblastic MC3T3-E1 Cells 2009 ·Hormone and Metabolic Research ·(unknown), (unknown), (unknown), Ippei Kanazawa, Kensuke Hayashi, Kenji Yamamoto, M. Yamauchi, T. Sugimoto	15
8	Correlation of Body Growth and Bone Mineral Density Measured by Ultrasound Densitometry of the Calcaneus in Children and Adolescents 2009 ·The Tohoku Journal of Experimental Medicine ·(unknown), (unknown), Akira Ohta, T. Sugimoto	7
9	Two-year Longitudinal Changes in Forearm Cortical Bone Geometry in Postmenopausal Women with Mild Primary Hyperparathyroidism without Parathyroidectomy 2008 ·Experimental and Clinical Endocrinology & Diabetes ·Hiroshi Kaji, Mika Yamauchi, (unknown), T. Sugimoto	2
10	The Combination of High Glucose and Advanced Glycation End-products (AGEs) Inhibits the Mineralization of Osteoblastic MC3T3-E1 Cells through Glucose-induced Increase in the Receptor for AGEs 2007 ·Hormone and Metabolic Research ·N. Ogawa, Toru Yamaguchi, Shozo Yano, M. Yamauchi, Masahiro Yamamoto, T. Sugimoto	110
11	The Usefulness of Bone Metabolic Indices for the Prediction of Changes in Bone Mineral Density after Parathyroidectomy in Patients with Primary Hyperparathyroidism 2006 ·Hormone and Metabolic Research ·Hiroshi Kaji, (unknown), M. Yamauchi, K Chihara, T. Sugimoto	17
12	Statins Modulate the Levels of Osteoprotegerin/Receptor Activator of NFκB Ligand mRNA in Mouse Bone-cell Cultures 2005 ·Hormone and Metabolic Research ·Hiroshi Kaji, Masanori Kanatani, T. Sugimoto, K Chihara	58
13	FGF-23 is a circulating factor that is elevated in oncogenic osteomalacia and X-linked hypophosphatemic rickets. 2002 ·Journal of Bone and Mineral Research ·Kenneth B. Jonsson, R Zahradnik, (unknown), Kenneth E. White, Geeta Hampson, A. Miyauchi, Östen Ljunggren, Hiroyuki Koshiyama, T. Sugimoto, Koichi Oba, Takehisa Yamamoto, Yasuo Imanishi, Michael J. Econs, Jeffrey R. Lavigne, Harald Jüeppner	8
14	Pharmacodynamics of Menatetrenone and Effects on Bone Metabolism in Continuous Ambulatory Peritoneal Dialysis Patients 2002 ·Journal of International Medical Research ·T. Sugimoto, Minoru Yamakado, Kazuyuki Matsushita, Takuya Iwamoto, Hitoshi Tagawa	7
15	Smad3 promotes ALP activity and mineralization of osteoblastic MC3T3-E1 cells: Involvement of type I collagen, osteocalcin and p38 MAP kinase. 2001 ·Journal of Bone and Mineral Research ·K Chihara, T. Sugimoto, (unknown), (unknown), Hideaki Sowa	1
16	The Action of GH/IGF-I/IGFBP in Osteoblasts and Osteoclasts 1997 ·Hormone Research ·Kazuo Chihara, T. Sugimoto	53
17	Activation of mitogen-activated protein kinase cascade in diabetic glomeruli and mesangial cells cultured under high glucose conditions. 1997 ·PubMed ·Masakazu Haneda, (unknown), Masaki Togawa, T. Sugimoto, Makoto Isono, Ryuichi Kikkawa	18
18	Role of Dual Signal Transduction Systems in the Stimulation of Bone Resorption by Parathyroid Hormone-Related Peptide 1993 ·Hormone and Metabolic Research ·Hidesuke Kaji, T. Sugimoto, M. Fukase, Kazuo Chihara	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact